Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Transverse myelopathy following intrathecal administration of chemotherapy

< Back to Listing

Share this Article

Singapore Med J 2007; 48(2): e46-e49
Transverse myelopathy following intrathecal administration of chemotherapy

  • Abstract
  • PDF

Teh HS, Fadilah SAW, Leong CF
Correspondence: Dr Teh Hiok Seng, hiokseng2005@gmail.com

ABSTRACT
Transverse myelopathy is one of the rare complications following administration of intrathecal chemotherapy. We report two cases of transverse myelopathy following administration of intrathecal methotrexate and cytarabine arabinoside. One patient was a 17-year-old Malay man who had lymphoblastic lymphoma in the leukaemic phase, while the other patient was a 40-year-old Malay man with relapsed Hodgkin's lymphoma. Both cases demonstrated variability in onset of symptoms, clinical progression and final outcome from the complication.

Keywords: chemotherapy complications, cytarabine arabinoside, intrathecal methotrexate, transverse myelopathy
Singapore Med J 2007; 48(2): e46–e49

http://smj.org.sg/sites/default/files/4802/4802cr5.pdf
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.